A standardized intraperitoneal Glucantime™ for experimental treatment of cutaneous leishmaniasis caused by Leishmania amazonensis in BALB/c mice

In vivo efficacy of meglumine antimoniate-loaded nanoparticles for cutaneous leishmaniasis: a systematic review

(2021) Meliana Borilli Pereira et al.   Nanomedicine

Sugar-Based Colloidal Nanocarriers for Topical Meglumine Antimoniate Application to Cutaneous Leishmaniasis Treatment: Ex vivo Cutaneous Retention and In vivo Evaluation

(2020) Thais Aragão Horoiwa et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice

(2019) Seyedeh Alia Moosavian et al.   EXPERIMENTAL PARASITOLOGY

In vitro and in vivo anti-parasitic activity of biogenic antimony sulfide nanoparticles on Leishmania major (MRHO/IR/75/ER)

(2019) Sina Mohtasebi et al.   PARASITOLOGY RESEARCH

Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis

(2019) Diana Caridha et al.   International Journal for Parasitology-Drugs and Drug Resistance

Short term impacts of meglumine antimoniate treatment on kidney function in dogs with clinical leishmaniosis

(2019) M.A. Daza González et al.   RESEARCH IN VETERINARY SCIENCE

Antileishmanial effect of rapamycin as an alternative approach to control Leishmania tropica infection

(2019) Fatemeh Khadir et al.   VETERINARY PARASITOLOGY

Polycaprolactone Antimony Nanoparticles as Drug Delivery System for Leishmaniasis

(2016) Ariane de Jesus Sousa-Batista et al.   AMERICAN JOURNAL OF THERAPEUTICS

Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)

(2016) Naomi Aronson et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro

(2016) Ana Paula Perez et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Poloxamer 407 (Pluronic® F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis

(2016) Débora V.C. Mendonça et al.   EXPERIMENTAL PARASITOLOGY

Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis

(2016) Juliane Lanza et al.   International Journal of Nanomedicine

Activity of synthetic chalcones in hamsters experimentally infected with Leishmania (Viannia) braziliensis

(2015) Tatiane F. P. de Mello et al.   PARASITOLOGY RESEARCH

A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis

(2015) Emily Rose Mears et al.   PLoS Neglected Tropical Diseases

Picrosirius Red Staining

(2014) Raed Lattouf et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Effect of HIV protease inhibitors on New World Leishmania

(2012) Izabel G. Demarchi et al.   PARASITOLOGY INTERNATIONAL